These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Yun J; Han M; Song C; Cheon SH; Choi K; Hahn HG Bioorg Med Chem Lett; 2014 Aug; 24(15):3234-7. PubMed ID: 24974340 [TBL] [Abstract][Full Text] [Related]
6. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers. Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876 [TBL] [Abstract][Full Text] [Related]
7. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361 [TBL] [Abstract][Full Text] [Related]
8. 4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists. Procopiou PA; Ancliff RA; Bamford MJ; Browning C; Connor H; Davies S; Fogden YC; Hodgson ST; Holmes DS; Looker BE; Morriss KM; Parr CA; Pickup EA; Sehmi SS; White GV; Watts CJ; Wilson DM; Woodrow MD J Med Chem; 2007 Dec; 50(26):6706-17. PubMed ID: 18052318 [TBL] [Abstract][Full Text] [Related]
9. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Cumming JG; Tucker H; Oldfield J; Fielding C; Highton A; Faull A; Wild M; Brown D; Wells S; Shaw J Bioorg Med Chem Lett; 2012 Feb; 22(4):1655-9. PubMed ID: 22266038 [TBL] [Abstract][Full Text] [Related]
10. Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors. Butini S; Campiani G; Franceschini S; Trotta F; Kumar V; Guarino E; Borrelli G; Fiorini I; Novellino E; Fattorusso C; Persico M; Orteca N; Sandager-Nielsen K; Jacobsen TA; Madsen K; Scheel-Kruger J; Gemma S J Med Chem; 2010 Jun; 53(12):4803-7. PubMed ID: 20481570 [TBL] [Abstract][Full Text] [Related]
11. Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition. Fox BM; Natero R; Richard K; Connors R; Roveto PM; Beckmann H; Haller K; Golde J; Xiao SH; Kayser F Bioorg Med Chem Lett; 2011 Apr; 21(8):2460-7. PubMed ID: 21414780 [TBL] [Abstract][Full Text] [Related]
12. Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors. Wu CH; Wang CJ; Chang CP; Cheng YC; Song JS; Jan JJ; Chou MC; Ke YY; Ma J; Wong YC; Hsieh TC; Tien YC; Gullen EA; Lo CF; Cheng CY; Liu YW; Sadani AA; Tsai CH; Hsieh HP; Tsou LK; Shia KS J Med Chem; 2015 Feb; 58(3):1452-65. PubMed ID: 25584630 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity. Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458 [TBL] [Abstract][Full Text] [Related]
17. De novo design of a picomolar nonbasic 5-HT(1B) receptor antagonist. Nugiel DA; Krumrine JR; Hill DC; Damewood JR; Bernstein PR; Sobotka-Briner CD; Liu J; Zacco A; Pierson ME J Med Chem; 2010 Feb; 53(4):1876-80. PubMed ID: 20088516 [TBL] [Abstract][Full Text] [Related]
18. Structure-based development of antagonists for chemokine receptor CXCR4. Zhang C; Hou T; Feng Z; Li Y Curr Comput Aided Drug Des; 2013 Mar; 9(1):60-75. PubMed ID: 22734712 [TBL] [Abstract][Full Text] [Related]
19. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists. Iyengar RR; Lynch JK; Mulhern MM; Judd AS; Freeman JC; Gao J; Souers AJ; Zhao G; Wodka D; Doug Falls H; Brodjian S; Dayton BD; Reilly RM; Swanson S; Su Z; Martin RL; Leitza ST; Houseman KA; Diaz G; Collins CA; Sham HL; Kym PR Bioorg Med Chem Lett; 2007 Feb; 17(4):874-8. PubMed ID: 17234405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]